PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product CRM and cardiac assist devices - Market size and forecast 2018-2023 Heart valve repair and replacement devices - Market size and forecast 2018-2023 Cardiopulmonary devices - Market size and forecast 2018-2023 Heart defect closure devices - Market size and forecast 2018-2023 Other thoracic surgery devices - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Strategic acquisitions Increasing number of thoracic surgeries Increasing focus on robotic surgeries PART 12: VENDOR LANDSCAPE Overview Landscape disruption PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott Laboratories Boston Scientific Corp. Edwards Lifesciences Corp. LivaNova Plc Medtronic Plc PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO LOE Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Product - Market share 2018-2023 (%) Exhibit 18: Comparison by product Exhibit 19: CRM and cardiac assist devices - Market size and forecast 2018-2023 ($ millions) Exhibit 20: CRM and cardiac assist devices - Year-over-year growth 2019-2023 (%) Exhibit 21: Heart valve repair and replacement devices - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Heart valve repair and replacement devices - Year-over-year growth 2019-2023 (%) Exhibit 23: Cardiopulmonary devices - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Cardiopulmonary devices - Year-over-year growth 2019-2023 (%) Exhibit 25: Heart defect closure devices - Market size and forecast 2018-2023 ($ millions) Exhibit 26: Heart defect closure devices - Year-over-year growth 2019-2023 (%) Exhibit 27: Other thoracic surgery devices - Market size and forecast 2018-2023 ($ millions) Exhibit 28: Other thoracic surgery devices - Year-over-year growth 2019-2023 (%) Exhibit 29: Market opportunity by product Exhibit 30: Customer landscape Exhibit 31: Market share by geography 2018-2023 (%) Exhibit 32: Geographic comparison Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 34: North America - Year-over-year growth 2019-2023 (%) Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Europe - Year-over-year growth 2019-2023 (%) Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 38: Asia - Year-over-year growth 2019-2023 (%) Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 40: ROW - Year-over-year growth 2019-2023 (%) Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Impact of drivers and challenges Exhibit 44: Cardiac devices new implant rates per 100,000 population between 2010 and 2015 Exhibit 45: Number of CABG procedures performed between 2010 and 2016 in various countries Exhibit 46: Vendor landscape Exhibit 47: Landscape disruption Exhibit 48: Vendors covered Exhibit 49: Vendor classification Exhibit 50: Market positioning of vendors Exhibit 51: Abbott Laboratories - Vendor overview Exhibit 52: Abbott Laboratories - Business segments Exhibit 53: Abbott Laboratories - Organizational developments Exhibit 54: Abbott Laboratories - Geographic focus Exhibit 55: Abbott Laboratories - Segment focus Exhibit 56: Abbott Laboratories - Key offerings Exhibit 57: Abbott Laboratories - Key customers Exhibit 58: Boston Scientific Corp. - Vendor overview Exhibit 59: Boston Scientific Corp. - Business segments Exhibit 60: Boston Scientific Corp. - Organizational developments Exhibit 61: Boston Scientific Corp. - Geographic focus Exhibit 62: Boston Scientific Corp. - Segment focus Exhibit 63: Boston Scientific Corp. - Key offerings Exhibit 64: Boston Scientific Corp. - Key customers Exhibit 65: Edwards Lifesciences Corp. - Vendor overview Exhibit 66: Edwards Lifesciences Corp. - Product segments Exhibit 67: Edwards Lifesciences Corp. - Organizational developments Exhibit 68: Edwards Lifesciences Corp. - Geographic focus Exhibit 69: Edwards Lifesciences Corp. - Segment focus Exhibit 70: Edwards Lifesciences Corp. - Key offerings Exhibit 71: Edwards Lifesciences Corp. - Key customers Exhibit 72: LivaNova Plc - Vendor overview Exhibit 73: LivaNova Plc - Business segments Exhibit 74: LivaNova Plc - Organizational developments Exhibit 75: LivaNova Plc - Geographic focus Exhibit 76: LivaNova Plc - Segment focus Exhibit 77: LivaNova Plc - Key offerings Exhibit 78: LivaNova Plc - Key customers Exhibit 79: Medtronic Plc - Vendor overview Exhibit 80: Medtronic Plc - Business segments Exhibit 81: Medtronic Plc - Organizational developments Exhibit 82: Medtronic Plc - Geographic focus Exhibit 83: Medtronic Plc - Segment focus Exhibit 84: Medtronic Plc - Key offerings Exhibit 85: Medtronic Plc - Key customers Exhibit 86: Validation techniques employed for market sizing Exhibit 87: Definition of market positioning of vendors  

Abbott Laboratories Boston Scientific Corp. Edwards Lifesciences Corp. LivaNova Plc Medtronic Plc